Motexafin gadolinium
Showing 1 - 25 of 318
Prostate Cancer Trial in Stanford (F18-DCFPyL, Gadolinium, Positron emission tomography (PET)/Magnetic Resonance Imaging (MRI)
Temporarily not available
- Prostate Cancer
- F18-DCFPyL
- +2 more
-
Stanford, CaliforniaStanford University
Apr 4, 2022
Non-Hodgkin's Lymphoma Trial in United States (Y-90-Zevalin, Moxtezafin Gadolinium, Rituximab)
Prostate Cancer Trial in Philadelphia (motexafin gadolinium)
Active, not recruiting
- Prostate Cancer
- motexafin gadolinium
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Oct 15, 2021
Breast Cancer, Chronic Myeloproliferative Disorders, Colorectal Cancer Trial in Pittsburgh, Madison (doxorubicin HCl, motexafin
Completed
- Breast Cancer
- +11 more
- doxorubicin hydrochloride
- motexafin gadolinium
-
Pittsburgh, Pennsylvania
- +1 more
Dec 12, 2019
Non-Hodgkin's Lymphoma (NHL) Trial in Chicago (Rituxan, motexafin gadolinium, 111Indium-Zevalin and 90Yttrium-Zevalin)
Breast Cancer Trial in Canada, United States (motexafin gadolinium, biopsy, breast imaging study)
Completed
- Breast Cancer
- motexafin gadolinium
- +5 more
-
San Francisco, California
- +11 more
Sep 23, 2019
Brain Metastases Trial in Dallas (Stereotactic Radiosurgery)
Recruiting
- Brain Metastases
- Stereotactic Radiosurgery
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Apr 29, 2022
Brain and CNS Tumors Trial (motexafin gadolinium, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- motexafin gadolinium
- radiation therapy
- (no location specified)
Jun 25, 2018
Untreated Childhood Brain Stem Glioma Trial in Philadelphia (motexafin gadolinium, 3-dimensional conformal radiation therapy)
Completed
- Untreated Childhood Brain Stem Glioma
- motexafin gadolinium
- 3-dimensional conformal radiation therapy
-
Philadelphia, PennsylvaniaChildren's Oncology Group
Dec 6, 2017
Gadolinium Deposition Disease Trial (Calcium DTPA and Zinc DTPA)
Not yet recruiting
- Gadolinium Deposition Disease
- Calcium DTPA and Zinc DTPA
- (no location specified)
Oct 26, 2022
Glioblastoma Multiforme, Adult, Recurrent Glioblastoma Trial in Rotterdam (Pitavastatin calcium)
Not yet recruiting
- Glioblastoma Multiforme, Adult
- Recurrent Glioblastoma
- Pitavastatin calcium
-
Rotterdam, NetherlandsErasmus MC
Aug 3, 2023
Relapsing Multiple Sclerosis Trial in Fort Collins, Farmington (Ublituximab)
Recruiting
- Relapsing Multiple Sclerosis
- Ublituximab
-
Fort Collins, Colorado
- +1 more
May 26, 2023
Liver Cancer Trial in United States (iodinated contrast dye, motexafin gadolinium, Eovist-enhanced MRI)
Active, not recruiting
- Liver Cancer
- iodinated contrast dye
- +2 more
-
Birmingham, Alabama
- +8 more
Oct 9, 2018
CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic
Recruiting
- Central Nervous System Neoplasm
- +2 more
- Ferumoxytol
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 2, 2022
Breast Benign Tumor, Breast Malignant Tumor Trial in Birmingham (Standard of Care (SOC) gadolinium Breast MRI, reduced 1/4 dose
Active, not recruiting
- Breast Benign Tumor
- Breast Malignant Tumor
- Standard of Care (SOC) gadolinium Breast MRI
- reduced 1/4 dose gadolinium Breast MRI with Artificial Intelligence (AI) to aid in evaluation.
-
Birmingham, AlabamaThe Kirklin Clinic
Dec 12, 2022
Gadolinium-based Contrast Agent Reduction in Brain MRI (MAGNET)
Recruiting
- Brain Diseases
- Low-dose GBCA levels
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Mar 2, 2023
Recurrent Cancer, Previous Radiation Trial (Radiation by protontherapy associated to nanoparticles injection)
Not yet recruiting
- Recurrent Cancer
- Previous Radiation
- Radiation by protontherapy associated to nanoparticles injection
- (no location specified)
Apr 19, 2022
Liver Cancer, Liver Cirrhoses, Liver Carcinoma Trial in La Jolla (Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid)
Recruiting
- Liver Cancer
- +2 more
- Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid
-
La Jolla, CaliforniaUniversity of California, San Diego
Apr 6, 2022
Relapsing Remitting Multiple Sclerosis Trial in Worldwide (Pleneva TM BGC20-0134, Placebo)
Terminated
- Relapsing Remitting Multiple Sclerosis
- Pleneva TM BGC20-0134
- Placebo
-
Gent, Belgium
- +34 more
Jun 2, 2022
Diffuse Intrinsic Pontine Glioma Trial in Milan (Nimotuzumab, Vinorelbine, Radiotherapy)
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Nimotuzumab
- +2 more
-
Milan, ItalyFondazione IRCCS Istituto Nazionale Tumori
Sep 3, 2021
A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging
Recruiting
- Heart Aneurysm
- Superparamagnetic Iron Oxide Nanoparticles
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Nov 18, 2023
Osteomyelitis Trial in Albuquerque (Ferumoxides 11.2Mg Solution for Injection)
Completed
- Osteomyelitis
- Ferumoxides 11.2Mg Solution for Injection
-
Albuquerque, New MexicoUniversity of New Mexico
Jul 17, 2023
Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma Trial in New York (Infusate with
Recruiting
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Infusate with MTX110 and gadolinium
- Convection-Enhanced Delivery (CED)
-
New York, New YorkColumbia University Irving Medical Center
Mar 8, 2022
Normal and Abnormal Cardiovascular Physiology Trial run by the NHLBI (MRI)
Recruiting
- Normal and Abnormal Cardiovascular Physiology
- MRI
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 18, 2022
Stepwise Strategy for Modifying Atrial Fibrillation Substrate
Recruiting
- Atrial Fibrillation
- late gadolinium enhanced magnetic resonance imaging
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Jul 26, 2022